Michal Cohen-Becker

The Eisenberg R&D Authority
Jerusalem, JM 91031, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Sex-Specific Association of Rasagiline with Motor Progression in GBA1-Associated Parkinson's Disease.

Sex-Specific Association of Rasagiline with Motor Progression in GBA1-Associated Parkinson's Disease.

Journal: Life (Basel, Switzerland)

Published: June 05, 2026

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.

Journal: International journal of molecular sciences

Published: March 25, 2026

The cutaneous phenotypic landscape of Gaucher disease type 1: a clinic-based cross-sectional study.

The cutaneous phenotypic landscape of Gaucher disease type 1: a clinic-based cross-sectional study.

Journal: Journal of the American Academy of Dermatology

Published: February 12, 2026

The cutaneous phenotypic landscape of Gaucher disease type 1: A clinic-based cross-sectional study.

The cutaneous phenotypic landscape of Gaucher disease type 1: A clinic-based cross-sectional study.

Journal: Journal of the American Academy of Dermatology

Published: February 12, 2026

Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease.

Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease.

Journal: American journal of hematology

Published: December 30, 2025

Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.

Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.

Journal: Life (Basel, Switzerland)

Published: April 21, 2025

Olfactory Perception in Parkinson's Disease: The Impact of GBA1 Variants (Sidransky Syndrome).

Olfactory Perception in Parkinson's Disease: The Impact of GBA1 Variants (Sidransky Syndrome).

Journal: International journal of molecular sciences

Published: April 06, 2025

GBA1-Associated Parkinson's Disease Is a Distinct Entity.

GBA1-Associated Parkinson's Disease Is a Distinct Entity.

Journal: International journal of molecular sciences

Published: June 04, 2024

Venglustat in GBA1-related Parkinson's disease.

Venglustat in GBA1-related Parkinson's disease.

Journal: The Lancet. Neurology

Published: September 20, 2023

Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.

Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.

Journal: Internal medicine journal

Published: February 15, 2023

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease.

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease.

Journal: International journal of molecular sciences

Published: January 23, 2023

The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy.

The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy.

Journal: Journal of clinical medicine

Published: January 05, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026